PHC agrees Innatus 3G evaluation deal
The US-based, UK-listed bioproducts company, Plant Health Care (PHC - Raleigh, North Carolina), has signed an agreement with an unnamed "major industry player in the agricultural space" to evaluate its Innatus 3G peptide platform. It allows the design, production and screening of a large pipeline of peptides with diverse biostimulant properties, PHC points out. They can be used for seed treatment and foliar applications for boosting disease resistance, drought tolerance and yield. The peptides can be combined with conventional crop protection products, making them highly complementary to existing production practices, PHC notes.